Setting

North America Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity

Published: 30 Jun 2021 | Report Code: 10248053 | Pages: 95

North America biosurgery market is expected to grow by 5.9% annually in the forecast period and reach $8,079.9 million by 2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population. Highlighted with 24 tables and 46 figures, this 95-page report “North America Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire North America biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country. Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hemostatic Agents • Bone-graft Substitutes o Synthetic Graft Extender o Demineralized Bone Matrix o Bone Morphogenetic Proteins o Cell-Based Matrices • Surgical Sealants and Adhesives o Natural Surgical Sealing Agents o Synthetic Surgical Sealing Agents • Soft-tissue Attachments o Natural & Biological Mesh/Patch o Synthetic Mesh/Patch • Adhesion Barriers o Natural Adhesion Barriers o Synthetic Adhesion Barriers • Staple Line Reinforcement Based on Source Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Orthopedic Surgery • General Surgery • Neurological Surgery • Cardiovascular Surgery • Gynecological Surgery • Other Applications Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): B. Braun Melsungen AG Baxter International, Inc. Becton, Dickinson and Company (C.R. Bard) Betatech Medical CryoLife Inc. CSL Limited Hemostasis LLC Integra Lifesciences Holdings Corporation Johnson & Johnson Medtronic PLC Pfizer, Inc. Sanofi S.A. Stryker Corporation (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction 5 1.1 Industry Definition and Research Scope 5 1.1.1 Industry Definition 5 1.1.2 Research Scope 6 1.2 Research Methodology 9 1.2.1 Overview of Market Research Methodology 9 1.2.2 Market Assumption 10 1.2.3 Secondary Data 10 1.2.4 Primary Data 10 1.2.5 Data Filtration and Model Design 11 1.2.6 Market Size/Share Estimation 12 1.2.7 Research Limitations 13 1.3 Executive Summary 14 2 Market Overview and Dynamics 16 2.1 Market Size and Forecast 16 2.1.1 Impact of COVID-19 on World Economy 17 2.1.2 Impact of COVID-19 on the Market 19 2.2 Major Growth Drivers 21 2.3 Market Restraints and Challenges 25 2.4 Emerging Opportunities and Market Trends 28 2.5 Porter’s Fiver Forces Analysis 32 3 Segmentation of North America Market by Product 36 3.1 Market Overview by Product 36 3.2 Hemostatic Agents 38 3.3 Bone-graft Substitutes 39 3.2.1 Synthetic Graft Extender 40 3.2.2 Demineralized Bone Matrix 41 3.2.3 Bone Morphogenetic Proteins 42 3.2.4 Cell-Based Matrices 43 3.4 Surgical Sealants and Adhesives 44 3.4.1 Natural Surgical Sealing Agents 45 3.4.2 Synthetic Surgical Sealing Agents 46 3.5 Soft-tissue Attachments 47 3.5.1 Natural & Biological Mesh/Patch 48 3.5.2 Synthetic Mesh/Patch 49 3.6 Adhesion Barriers 50 3.6.1 Natural Adhesion Barriers 51 3.6.2 Synthetic Adhesion Barriers 52 3.7 Staple Line Reinforcement 53 4 Segmentation of North America Market by Source Type 54 4.1 Market Overview by Source Type 54 4.2 Natural/Biological Products 56 4.3 Synthetic Products 57 5 Segmentation of North America Market by Application 59 5.1 Market Overview by Application 59 5.2 Orthopedic Surgery 61 5.3 General Surgery 62 5.4 Neurological Surgery 63 5.5 Cardiovascular Surgery 64 5.6 Gynecological Surgery 65 5.7 Other Applications 66 6 North America Market 2020-2027 by Country 67 6.1 Overview of North America Market 67 6.2 U.S. 70 6.3 Canada 73 6.4 Mexico 75 7 Competitive Landscape 77 7.1 Overview of Key Vendors 77 7.2 New Product Launch, Partnership, Investment, and M&A 80 7.3 Company Profiles 81 B. Braun Melsungen AG 81 Baxter International, Inc. 83 Becton, Dickinson and Company (C.R. Bard) 84 Betatech Medical 85 CryoLife Inc. 86 CSL Limited 87 Hemostasis LLC 88 Integra Lifesciences Holdings Corporation 89 Johnson & Johnson 90 Medtronic PLC 91 Pfizer, Inc. 92 Sanofi S.A. 93 Stryker Corporation 94 RELATED REPORTS 95
List Of Tables

Table 1. Snapshot of North America Biosurgery Market in Balanced Perspective, 2020-2027 15 Table 2. Growth Rate of World GDP, 2020-2022 18 Table 3. Main Product Trends and Market Opportunities in North America Biosurgery Market 28 Table 4. North America Biosurgery Market by Product, 2017-2027, $ mn 36 Table 5. North America Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, $ mn 39 Table 6. North America Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, $ mn 44 Table 7. North America Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, $ mn 47 Table 8. North America Biosurgery Market: Adhesion Barriers by Type, 2017-2027, $ mn 50 Table 9. North America Biosurgery Market by Source Type, 2017-2027, $ mn 54 Table 10. North America Biosurgery Market by Application, 2017-2027, $ mn 59 Table 11. North America Biosurgery Market by Country, 2017-2027, $ mn 68 Table 12. U.S. Biosurgery Market by Product, 2017-2027, $ mn 72 Table 13. U.S. Biosurgery Market by Source Type, 2017-2027, $ mn 72 Table 14. U.S. Biosurgery Market by Application, 2017-2027, $ mn 72 Table 15. Canada Biosurgery Market by Product, 2017-2027, $ mn 74 Table 16. Canada Biosurgery Market by Source Type, 2017-2027, $ mn 74 Table 17. Canada Biosurgery Market by Application, 2017-2027, $ mn 74 Table 18. Mexico Biosurgery Market by Product, 2017-2027, $ mn 76 Table 19. Mexico Biosurgery Market by Source Type, 2017-2027, $ mn 76 Table 20. Mexico Biosurgery Market by Application, 2017-2027, $ mn 76 Table 21. B. Braun Melsungen AG: Company Snapshot 81 Table 22. B. Braun Melsungen AG: Business Segmentation 81 Table 23. B. Braun Melsungen AG: Product Portfolio 82 Table 24. B. Braun Melsungen AG: Revenue, 2017-2019, $ mn 82
List Of Figures

Figure 1. Research Method Flow Chart 9 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 12 Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 14 Figure 4. North America Biosurgery Market, 2017-2027, $ mn 16 Figure 5. Impact of COVID-19 on Business 19 Figure 6. Primary Drivers and Impact Factors of North America Biosurgery Market 21 Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 24 Figure 8. Primary Restraints and Impact Factors of North America Biosurgery Market 25 Figure 9. Investment Opportunity Analysis 29 Figure 10. Porter’s Fiver Forces Analysis of North America Biosurgery Market 32 Figure 11. Breakdown of North America Biosurgery Market by Product, 2020-2027, % of Revenue 36 Figure 12. Contribution to North America 2021-2027 Cumulative Revenue by Product, Value ($ mn) and Share (%) 37 Figure 13. North America Biosurgery Market: Hemostatic Agents, 2017-2027, $ mn 38 Figure 14. North America Biosurgery Market: Bone-graft Substitutes, 2017-2027, $ mn 39 Figure 15. North America Biosurgery Market: Synthetic Graft Extender, 2017-2027, $ mn 40 Figure 16. North America Biosurgery Market: Demineralized Bone Matrix, 2017-2027, $ mn 41 Figure 17. North America Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, $ mn 42 Figure 18. North America Biosurgery Market: Cell-Based Matrices, 2017-2027, $ mn 43 Figure 19. North America Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, $ mn 44 Figure 20. North America Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, $ mn 45 Figure 21. North America Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, $ mn 46 Figure 22. North America Biosurgery Market: Soft-tissue Attachments, 2017-2027, $ mn 47 Figure 23. North America Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, $ mn 48 Figure 24. North America Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, $ mn 49 Figure 25. North America Biosurgery Market: Adhesion Barriers, 2017-2027, $ mn 50 Figure 26. North America Biosurgery Market: Natural Adhesion Barriers, 2017-2027, $ mn 51 Figure 27. North America Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, $ mn 52 Figure 28. North America Biosurgery Market: Staple Line Reinforcement, 2017-2027, $ mn 53 Figure 29. Breakdown of North America Biosurgery Market by Source Type, 2020-2027, % of Revenue 54 Figure 30. Contribution to North America 2021-2027 Cumulative Revenue by Source Type, Value ($ mn) and Share (%) 55 Figure 31. North America Biosurgery Market: Natural/Biological Products, 2017-2027, $ mn 56 Figure 32. North America Biosurgery Market: Synthetic Products, 2017-2027, $ mn 57 Figure 33. Breakdown of North America Biosurgery Market by Application, 2020-2027, % of Revenue 60 Figure 34. Contribution to North America 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%) 60 Figure 35. North America Biosurgery Market: Orthopedic Surgery, 2017-2027, $ mn 61 Figure 36. North America Biosurgery Market: General Surgery, 2017-2027, $ mn 62 Figure 37. North America Biosurgery Market: Neurological Surgery, 2017-2027, $ mn 63 Figure 38. North America Biosurgery Market: Cardiovascular Surgery, 2017-2027, $ mn 64 Figure 39. North America Biosurgery Market: Gynecological Surgery, 2017-2027, $ mn 65 Figure 40. North America Biosurgery Market: Other Applications, 2017-2027, $ mn 66 Figure 41. Breakdown of North America Biosurgery Market by Country, 2020 and 2027, % of Revenue 68 Figure 42. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 69 Figure 43. U.S. Biosurgery Market, 2017-2027, $ mn 71 Figure 44. Canada Biosurgery Market, 2017-2027, $ mn 73 Figure 45. Biosurgery Market in Mexico, 2017-2027, $ mn 75 Figure 46. Growth Stage of North America Biosurgery Industry over the Forecast Period 77
Key Players (this may not be a complete list and extra companies can be added upon request): 
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.
Stryker Corporation
 (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)